• <tr id="yyy80"></tr>
  • <sup id="yyy80"></sup>
  • <tfoot id="yyy80"><noscript id="yyy80"></noscript></tfoot>
  • 99热精品在线国产_美女午夜性视频免费_国产精品国产高清国产av_av欧美777_自拍偷自拍亚洲精品老妇_亚洲熟女精品中文字幕_www日本黄色视频网_国产精品野战在线观看 ?

    Acrylamide inhibits nerve sprouting induced by botulinum toxin type A

    2014-04-06 11:30:58HongJiangYiXiangXingyueHuHuayingCai

    Hong Jiang, Yi Xiang, Xingyue Hu, Huaying Cai

    1 Department of Neurology, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang Province, China

    2 Second Clinical Medical College, Zhejiang Chinese Medical University, Hangzhou, Zhejiang Province, China

    Acrylamide inhibits nerve sprouting induced by botulinum toxin type A

    Hong Jiang1, Yi Xiang2, Xingyue Hu1, Huaying Cai1

    1 Department of Neurology, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang Province, China

    2 Second Clinical Medical College, Zhejiang Chinese Medical University, Hangzhou, Zhejiang Province, China

    Botulinum toxin type A is a potent muscle relaxant that blocks the transmission and release of acetylcholine at the neuromuscular junction. Intramuscular injection of botulinum toxin type A has served as an effective and safe therapy for strabismus and focal dystonia. However, muscular weakness is temporary and after 3-4 months, muscle strength usually recovers because functional recovery is mediated by nerve sprouting and reconstruction of the neuromuscular junction. Acrylamide may produce neurotoxic substances that cause retrograde necrotizing neuropathy and inhibit nerve sprouting caused by botulinum toxin type A. This study investigated whether acrylamide inhibits nerve sprouting after intramuscular injection of botulinum toxin type A. A tibial nerve sprouting model was established through local injection of botulinum toxin type A into the right gastrocnemius muscle of Sprague-Dawley rats. Following intramuscular injection, rats were given intraperitoneal injection of 3% acrylamide every 3 days for 21 days. Nerve sprouting appeared 2 weeks after intramuscular injection of botulinum toxin type A and single-fiber electromyography revealed abnormal conduction at the neuromuscular junction 1 week after intramuscular injection of botulinum toxin type A. Following intraperitoneal injection of acrylamide, the peak muscle fi ber density decreased. Electromyography jitter value were restored to normal levels 6 weeks after injection. This indicates that the maximal decrease in fi ber density and the time at which functional conduction of neuromuscular junction was restored were delayed. Additionally, the increase in tibial nerve fi bers was reduced. Acrylamide inhibits nerve sprouting caused by botulinum toxin type A and may be used to prolong the clinical dosage of botulinum toxin type A.

    nerve regeneration; peripheral nerve regeneration; botulinum toxin type A; acrylamide; nerve sprouting; electromyography; nerve fibers; neuromuscular junction; single-fiber EMG; fiber density; action potential mean consecutive difference; dysmyotonia; neural regeneration

    Funding:This study was supported by TCM General Research Project of Zhejiang Province, No. 2014ZA071; Health General Research Project of Zhejiang Province, No. 2014KYA106.

    Jiang H, Xiang Y, Hu XY, Cai HY. Acrylamide inhibits nerve sprouting induced by botulinum toxin type A. Neural Regen Res. 2014;9(16):1525-1531.

    Introduction

    Botulinum toxin type A (BTX-A), one of the exotoxins produced by Clostridium botulinum, can selectively act on the presynaptic membrane of peripheral cholinergic motor neurons. It cleaves synaptosomal associated protein 25 kDa (SNAP-25), which consequently inhibits the release of acetylcholine containing vesicles from presynaptic membranes, blocks neuromuscular transmission, and leads to flaccid paralysis in the target muscles (Blasi et al., 1993; Brin, 1997; Rossetto et al., 2006). Based on the above mechanism of action, BTX-A has been used to treat strabismus and subsequently dystonia and cluster headache, which are characterized by excessive or inappropriate muscle contractions (Allison et al., 2012; Chen, 2012; Bragg et al., 2014; Thenganatt et al., 2014). Owing to its safety and effectiveness, BTX-A has been extensively used for clinical treatment in the fi elds of neurology (Villafa?e et al., 2012), ophthalmology (Ho et al., 2014), plastic surgery (Winocour et al., 2014), rehabilitation medicine (Pimentel et al., 2014), gastroenterology (Blake et al., 2012) and urology (Rashid et al., 2013).

    However, BTX-A treatment is limited by its short ef fi cacy, single administration is effective for only 3-4 months, which means that patients have to receive repeated injections. Increasing the dosage of single administration may prolong the effectiveness of the duration of the drug, but it may also aggravate the immune response and produce botulinum toxin antibodies; hence reducing the efficacy and safety of long-term treatment. The effectiveness of drug duration depends on the functional recovery of conduction at the neuromuscular junction, which is mediated by nerve sprouting and reconstruction of the neuromuscular junction (Holds et al., 1990; Juzans et al., 1996; Paiva et al., 1999; English, 2003; Harrison et al., 2007; Wright et al., 2007). BTX-A treatment blocks vesicular acetylcholine release for 3 days, nerve terminals begin to produce sprouting nerves, the number of acetylcholine receptors increases, and new neuromuscularjunctions form. Between 4 and 8 weeks after BTX-A injection, the number of neuromuscular junctions remains the same, conduction at the blocked neuromuscular junction is restored, and sprouting nerves gradually retreat. As yet, there is no method to prolong the duration of the effect of the drug, and this is worthy of further study.

    Acrylamide monomer is moderately toxic and mainly affects the nervous system. It is also a typical neurotoxic substance that causes retrograde necrotizing neuropathy (Matthew et al., 1983; Lopachin et al., 2008; Scelsi et al., 2012). Acrylamide accumulates highly speci fi cally in the body and the degree of intoxication is closely related to the cumulative dose. Mild poisoning leads to sensorineural polyneuropathy with insidious onset; moderate poisoning is mainly an ataxia disorder caused by deep sensory disorder; severe poisoning leads to subacute onset of cerebellar dysfunction, followed by sensorimotor polyneuropathy. The symptoms may disappear after several weeks or months. The pathology of the peripheral nerve is consistent axonal degeneration. Silver-cholinesterase double staining shows early swelling of motor nerve terminals in the last node of Ranvier, and gradual deterioration at the proximal end, even at the neuromuscular junction. Large numbers of neuro fi laments aggregate in the swelling axons, with degenerating mitochondria and granules. As the poisoning intensifies, axonal degeneration exacerbates, myelin sheath dissociates and an oval cell body forms, ultimately leading to complete destruction or disintegration of the nerve fibers (Dale et al., 2002; Xiao et al., 2013). The mechanisms of poisoning include acrylamide inhibition of axonal transport, energy metabolism disorders and calcium overload (Zhu et al., 2008). Whether acrylamide inhibits nerve sprouting caused by intramuscular injection of BTX-A is poorly understood.

    In this study, a nerve sprouting model was established through local injection of BTX-A into the right gastrocnemius muscle in rats (Pestronk et al., 1988), and the effect of acrylamide on nerve sprouting after intramuscular injection of BTX-A was investigated. Nerve sprouting was studied pathologically and electrophysiologically in a broader attempt to explore the possibility of acrylamide inhibiting nerve sprouting.

    Materials and Methods

    Animals

    A total of 145 adult Sprague-Dawley rats of clean grade II, weighing 160-200 g, were provided by the Animal Center of Zhejiang Academy of Medical Sciences, China (license No. SYXK (Zhejiang) 2010-0149). Experimental protocols were approved by Animal Ethics Committee of Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, China.

    Establishment of animal models and grouping

    One hundred and forty-five rats were randomly divided into four groups: normal control group (n= 10), BTX-A group (n= 45), BTX-A + acrylamide group (n= 45), and acrylamide group (n= 45). Except for the normal control group, each rat in the other three groups was conventionally disinfected with PVP-I and injected with 5 U BTX-A into the right side of the gastrocnemius muscle (Lanzhou Institute of Biological Products, Ministry of Health, Lanzhou, China; license No. (97) (Lan) S-01) or saline (0.2 mL). At 3, 6, 9, 12, 15, 18, 21 days after intramuscular injection, rats were given intraperitoneal injection of 3% acrylamide (Jiangsu Yonghua Chemical Co., Ltd., Suzhou, Jiangsu Province, China) or saline 0.1 mL. Following seven injections, the cumulative acrylamide dose reached 21 mg, which was equal to 105-131 mg/kg body weight. In the BTX-A + acrylamide, BTX-A, and acrylamide groups, every fi ve rats were randomly selected at different time points (1, 2, 3, 4, 6, 8, 10, 12, 24 weeks) after BTX-A or saline injection to assess the right hindlimb muscle strength, detect electrophysiological and morphological examinations, and quantify nerve fibers. Normal control group was assayed without any treatment. A single-blind method was adopted for the determinations.

    Muscle strength

    The score of muscle strength in the rat right hindlimb was evaluated according to the methods of Longa et al. (1989). 0: No neurological de fi cit symptoms; 1: rats cannot fully extend right hindlimbs; 2: rats circling; 3: rats tilt to the right side when walking; 4: rats cannot spontaneously walk or are in a coma.

    Single- fi ber electromyography (EMG)

    Single-fiber EMG was recorded in each rat at 1, 2, 3, 4, 6, 8, 10, 12, 24 weeks after BTX-A or saline injection. Rats were intraperitoneally anesthetized using 50 mg/mL sodium thiopental and fi xed on the operation bench. The right hindlimbs were shaved to expose the popliteal fossa. The gastrocnemius branch innervated by the sciatic nerve was disinfected with PVP-I and detected with EMG for electrophysiological examination. Stimulating needle electrodes were inserted into the gastrocnemius branches and single- fi ber recording needle electrodes were inserted into the gastrocnemius muscle belly. The inserted electrodes were continuously moving to find the appropriate single-fiber action potentials (the peak-peak amplitude > 200 μV; the time of positive peak-negative peak < 300 μs; stable continuous waveform) (Lu et al., 2000). The electrical stimulation parameters were: frequency 10 Hz, intensity 4 mA, discharge 100 times. Six single-fiber EMG images photographed in different locations of gastrocnemius muscle were collected and automatically stored on computer to analyze action potential mean consecutive difference (MCD) and muscle fi ber density. Single- fi ber EMG techniques included two parameters: jitter and fi ber density. Jitter is also known as the MCD and neuromuscular dysfunction may prolong MCD. Fiber density refers to the number of single- fi ber action potentials in the range of 300 μm electrodes, and the increasing fi ber density indicates reinnervation (Lu et al., 2000; Restivo et al., 2012).

    Gastrocnemius muscle weight

    Figure 1 Single- fi ber action potential of gastrocnemius muscle of rats during nerve sprouting.

    Figure 2 Fiber density of gastrocnemius muscle of rats during nerve sprouting.

    After electrophysiological examination, rats were sacri fi ced by femoral artery bleeding and the bilateral gastrocnemius was quickly harvested, removing the surface fat and connective tissue. The gastrocnemius muscles were weighed using an analytical balance.

    Pathological observation

    At 1, 2, 3, 4, 6, 8, 10, 12, 24 weeks after BTX-A or saline injection, pathology of the gastrocnemius muscle was performed to observe nerve sprouting. The right side gastrocnemius muscle was frozen and sliced into 20 μm sections for Gros-Bielschowsky silver staining (Angaut-Petit et al., 1990). A low-power field (10 × magnification) from two slices of five rats in each group at each time point was randomly selected and observed under light microscope. The images were photographed using JVC1381 type color photography camera (Nikon, Tokyo, Japan), input into the computer, and analyzed using HPIAS-1000 high-resolution color analysis system (Tongji Medical College, Huazhong University of Science and Technology, Shanghai, China). The number of nerve fi bers per unit area was calculated. DMR microscope (Leica, Germany) was used to observe pathological fi ndings.

    Figure 3 Changes of mean consecutive difference (MCD) of rat

    Statistical analysis

    Measurement data were expressed as mean ± SD, and analyzed using SPSS 21.0 software (SPSS, Chicago, IL, USA), one-way analysis of variance and the least signi fi cant difference test.P< 0.05 was considered signi fi cant.

    Results

    Effect of BTX-A plus acrylamide on single- fi ber EMG of rat gastrocnemius muscles

    The fi ber density of the normal control group was 2.2 ± 0.4. There was no significant difference in the fiber density between acrylamide group and normal control group (P> 0.05). As shown in Figures 1 and 2, fi ber density was increased in the BTX-A group and reached a peak at 4-6 weeks (5.6 ± 0.7;P< 0.05), gradually declined, and returned to normal levels at 12 weeks, suggesting neural sprouting. After BTX-A plus acrylamide injection, fiber density decreased significantly (P< 0.05) and there was a delay in peak sprouting whichwas observed at 8-10 weeks at 4.6 ± 0.8, signi fi cantly lower than the BTX-A group. These results suggest acrylamide inhibited nerve sprouting after intramuscular injection of BTX-A.

    The action potential MCD of normal control group was 33 ± 4 μs. As shown in Figure 3, acrylamide intervention alone had no impact on MCD (compared with normal control group,P> 0.05). Intramuscular injection of BTX-A prolonged the action potential MCD suggesting neuromuscular junction conduction abnormalities. Prolonged MCD was most apparent in the BTX-A group at 3-6 weeks (P< 0.05), slightly improved at 8-10 weeks and returned to normal levels at 12 weeks (compared with the control group,P> 0 05). In the BTX-A + acrylamide group, MCD was significantly longer compared with the BTX-A group at 8-12 weeks (P< 0.05), indicating BTX-A plus acrylamide delayed the functional recovery of neuromuscular junction.

    Effect of BTX-A plus acrylamide on nerve fi ber counts of rat gastrocnemius muscles

    As shown in Figure 4, nerve sprouting occurred after intramuscular injection of BTX-A. At 2-3 weeks after injection, thin and short sprouting nerves grew from the axonal terminal of the tibial nerve and gradually extended towards adjacent muscles. In the normal control group, the number of nerve fibers at the right side of the tibial nerve was 5.52 ± 0.09 × 108/m2. There was no signi fi cant difference in fi ber density between the acrylamide group and normal control group (P> 0.05). The number of nerve fibers increased at 2-12 weeks after BTX-A interventions (P< 0.05), and the increase was the most obvious at 4-6 weeks (P< 0.05). After injection of BTX-A plus acrylamide, the increase in the number of nerve fi bers was signi fi cantly reduced (P < 0.05), the peak time of sprouting was delayed to 8-10 weeks, and the peak value was 10.65 ± 0.32 × 108/m2(P< 0.05), which was significantly lower than that in the BTX-A group (14.33 ± 0.45 × 108/m2;P< 0.05; Figure 5). These results indicate acrylamide inhibits neural sprouting after intramuscular injection of botulinum toxin.

    Effect of BTX-A plus acrylamide on muscle strength of rats

    The rats showed normal muscle strength in the normal control group. Acrylamide injection alone had no obvious impact on muscle strength (compared with the normal control group,P> 0.05). One week after intramuscular injection of BTX-A, hind limb dysmyotonia appeared which began to recover at 6 weeks and restored to normal levels at 12 weeks (P> 0 05). In the BTX-A + acrylamide group, the dysmyotonia began to recover at 8-10 weeks post-injection, and restored to normal levels at 24 weeks, indicating that acrylamide delayed muscle strength recovery (Figure 6). At each time point, the muscle strength on the non-injected side was normal after the injections (BTX-A group and BTX-A + acrylamide group) and in the normal control group, suggesting that BTX-A injections into the right gastrocnemius did not cause contralateral muscle paralysis and had no distant effects.

    Effect of BTX-A plus acrylamide on wet weight of gastrocnemius muscle of rats

    As shown in Figure 7, the wet weight of gastrocnemius muscle in BTX-A group 1 week after BTX-A injection was 67.6% of the normal control group after saline injection (P< 0.05). Four weeks post-injection, the wet weight on the side of injection decreased to its lowest level, 41.6% of the normal control group. The weight then increased but was 51.8% at 12 weeks and 88.8% at 24 weeks when compared with the normal control group. However, the wet weight was still significantly lower than the gastrocnemius wet weight after saline injection in the normal control group (P< 0.05). The gastrocnemius wet weight was similar after injection of BTX-A plus acrylamide or BTX-A alone (P> 0.05), suggesting acrylamide does not aggravate muscle atrophy. There was no significant difference in gastrocnemius wet weight on the non-injected side between the injection groups (BTX-A group, BTX-A plus acrylamide group, acrylamide group) and the normal control group (P> 0.05). BTX-A injections into the right gastrocnemius muscle may not decrease the weight of contralateral gastrocnemius and has no distant effects.

    Discussion

    BTX-A exerts a selective effect on the presynaptic membrane of the neuromuscular junction, inhibiting the release of acetylcholine and relaxing the muscle (Simpson, 1981). It has been widely used for treatment in the fi elds of neurology, rehabilitation, and plastic surgery. However, the muscle relaxant effect is temporary and lasts only 3-4 months. Its mechanism of action is mediated by the sprouting of axon terminals and the reversal of presynaptic membrane proteins to restore the transmission effect of neuromuscular junction, thus achieving muscle strength recovery (Brin, 1997). There are many indexes for evaluating nerve sprouting and we chose two indicators for both pathological and electrophysiological evaluation. Gros-Bieschowsky sliver staining was used to display nerve fi bers and count nerve fi bers based on image analysis results. This counting method has been widely used (Brin, 1997; Pestronk et al., 1988; Meekins et al., 2007). Electrophysiology examination involved adopting a single- fi ber EMG, a sensitive indicator of the neuromuscular junction that can re flect electrical activity of different muscle fi bers and their motor end plates per motor unit. The measurement parameters include jitter and fi ber density, which are indicators of axonal regeneration activity (Bril et al., 1996). Jittering re flects neuromuscular function, which can be expressed as action potential MCD; increasing MCD represents neurological defects. Fiber density re flects the distribution of muscle fi bers per motor unit, collateral sprouting can rebuild motor unit, and increase muscle fi bers’ quantity and density. In this study, we used the pathology counting method and fiber density to observe the number of nerve fi bers, and measured muscular strength and action potential MCD to assess neuromuscular function.

    Nerve sprouting appeared 3-5 days after intramuscular injection of BTX-A which gradually became longer, withextended branches and sprouts crossing through the paralyzed muscles and forming new neuromuscular junctions and ultimately achieving muscle contraction again with the process taking about 12 weeks (Santafe et al., 2000; Meunier et al., 2002; Shen et al., 2006; Harrison et al., 2011). In this study, we observed the nerve sprouting process by counting nerve fibers and detecting neuromuscular function. The number of nerve sprouts was quanti fied from sections and fi ber density was detected by single- fi ber EMG. The results showed that nerve sprouting appeared after intramuscular injection of BTX-A and declined at 6 weeks. This is inconsistent with the study by Santafe et al., who found nerve sprouting continuously increased for 12 months post-injection. The decline at 6 weeks is presumably due to the mature function of neuromuscular junction inducing a signal for the closure of sprouting. It is also the result of excessive sprout degeneration, ensuring that a muscle fiber is only innervated by one or two synapses. Neuromuscular junction function is mainly indicated by MCD. The results of this study showed that MCD increased 1 week after BTX-A injection, signi fi cantly increased at 3-6 weeks, then slightly improved at 8-10 weeks, and restored to normal levels at 12 weeks. The increasing MCD is attributed to at least two mechanisms: (1) BTX-A directly acts on neuromuscular junction; (2) new neuromuscular junction formed by nerve sprouting is immature. During the nerve sprouting process, the immature neuromuscular junction slows conduction impulse more than the originally located motor units, so MCD is increased; while mature neuromuscular function leads to normalized MCD. Muscle strength recovery observed in this study indicated the maturity of neuromuscular junction. Our experimental fi ndings were consistent with the results of Santafe and Harrison et al., who found that the neuromuscular junction became mature at 12 weeks (Santafe et al., 2000; Meunier et al., 2002; Harrison et al., 2007, 2011). In summary, intramuscular injection of BTX-A triggers nerve sprouting, and neuromuscular junction can be reconstructed at 12 weeks.

    The results of this study suggest acrylamide inhibits nerve sprouting after intramuscular injection of BTX-A. Quantifi cation of nerve sprouting and nerve fi ber density showed that acrylamide delayed the peak of nerve sprouting after intramuscular injection of BTX-A and generally inhibited nerve sprouting. In BTX-A plus acrylamide group, fiber density was increased within 12 weeks, but the density was lower than BTX-A group and the increasing trend was not obvious at 2-6 weeks; in the BTX-A plus acrylamide group, fi ber density peaked at 8 weeks, which was 4 weeks later than BTX-A group; additionally, fi ber density peak value was lower than the BTX-A group. Nerve fi ber counts were generally consistent with the fiber density results. MCD detection results also demonstrated that, acrylamide inhibited the recovery of neuromuscular function. There was no signi fi cant difference between BTX-A group and BTX-A plus acrylamide group at 1-6 weeks post-injection, but the MCD was significantly abnormal in BTX-A plus acrylamide group at 8-12 weeks. Meanwhile, the muscle strength monitored was similar to the detection results of MCD. This illustrated that neuromuscular function recovery in BTX-A + acrylamide group was significantly slower than that in BTX-A group. Both the number of nerve sprouts (anatomy) and immaturity of nerve sprouting (function) suggest that acrylamide inhibited nerve sprouting after intramuscular injection of BTX-A. This effect may be related to the neurotoxicity of acrylamide. Previous studies have reported that the mechanisms associated with acrylamide-induced peripheral nerve injury include inhibition of axonal transport, inhibition of energy metabolism, and calcium overload (Matthew et al., 1983; Costa et al., 1995; Hao et al., 2000; Dale et al., 2002; Sickles et al., 2002; Lopachin et al., 2008; Zhu et al., 2008; Scelsi et al., 2012; Prasad et al., 2013; Xiao et al., 2013). We speculate that these factors lead to a de fi ciency of energy and raw materials at the axonal terminals, and accordingly inhibit nerve sprouting after intramuscular injection of BTX-A. Further studies are needed to explore the mechanisms.

    Although acrylamide inhibited nerve sprouting at the gastrocnemius muscle, it had no impact on neuromuscular function in normal muscle and did not induce neurological impairment (such as hindlimb weakness, inability to walk, and muscle atrophy) and nerve regeneration after injury. This can be explained by the different doses and neurotoxicity of acrylamide. Acrylamide poisoning is determined by the cumulative dose: rats exposed to cumulative doses of 75 mg/kg have slowed axonal transport, 180 mg/kg acrylamide slowed down nerve conduction velocity, and 225 mg/kg caused neurological symptoms (such as hindlimb weakness) (Li et al., 1989; Zhang et al., 2008). In this study, exposure dose reached 105-131 mg/kg. Second, there are differences in the sensitivity of peripheral nerve to poisoning. Previous studies found that the symptoms of poisoning were most apparent in the lower extremity of experimental animals or humans because thick myelinated fi bers are more prone to damage. Among peripheral nerves, the sciatic nerve is the most sensitive and axonal degeneration fi rst appears in the gastrocnemius muscle, therefore the sciatic nerve accumulates more poison than other sites (Dong et al., 1994).

    In summary, acrylamide could inhibit nerve sprouting after intramuscular injection of BTX-A, which explores a novel way for prolonging the ef fi cacy of BTX-A and solving nerve sprouting following intramuscular injection of BTX-A. Any clinical signi fi cance needs further study. Acrylamide has potential neurotoxicity, genotoxicity and carcinogenicity, which needs further investigation at the injection way, optimal dose and systemic toxicity. The mechanism of action associated with BTX-A triggering nerve sprouting remains unclear, but at least four cytokines are involved in the process of nerve sprouting, including insulin-like growth factor, nerve interleukin, ciliary neurotrophic factor, and cell adhesion molecules (Caroni et al., 1994a, b; English, 2003; Carli et al., 2009). Further studies are needed to investigate the molecular mechanisms of neural sprouting, to fi nd a feasible method to inhibit neuronal sprouting, and to prolong the ef fi cacy and duration of BTX-A (Harrison et al., 2011; Guo et al., 2013).

    Figure 4 Nerve sprouting after intramuscular injection of botulinum toxin type A in the right side of rat gastrocnemius muscles (Gros-Bielschowsky silver staining, × 200).

    Figure 5 Effect of botulinum toxin type A (BTX-A) and acrylamide (Acr) on tibial nerve fi bers count in rats.

    Figure 6 Effect of botulinum toxin type A (BTX-A) plus acrylamide (Acr) on muscle strength of rats.

    Figure 7 The wet weight of right gastrocnemius muscle of rats after BTX-A injection.

    Author contributions:Jiang H was responsible for electro-physiological examination, performing statistical analysis, and writing the manuscript. Cai HY conducted pathological exam-ination, designed the study and implemented the experiment. Hu XY and Xiang Y instructed the experiments. All authors approved the final version of the manuscript.

    Acknowledgments:We would like to thank Dr. Shao YQ from Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, China for guiding neuropathological staining.

    Con flicts of interest:None declared.

    Allison R, Knapp KM (2012) Spasticity management with botulinum toxin: development and evaluation of a tool for audit. J Rehabil Med 44:558-561.

    Angaut-Petit D, Molgo J, Comella JX, Faille L, Tabti N (1990) Terminal sprouting in mouse neuromuscular junctions poisoned with botulinum type A toxin: morphological and electrophysiological features. Neuroscience 37:799-808.

    Bertorini TE, Stalberg E, Yuson CP, Engel WK (1994) Single- fi ber electromyography in neuromuscular disorders: correlation of muscle histochemistry, single- fi ber electromyography, and clinical fi ndings. Muscle Nerve 17:345-353.

    Blake KD, MacCuspie J, Corsten G (2012) Botulinum toxin injections into salivary glands to decrease oral secretions in CHARGE syndrome: prospective case study. Am J Med Genet A 158:828-831.

    Blasi J, Chapman ER, Link E, Binz T, Yamasaki S, De Camilli P, Sudhof T, Niemann H, Jahn R (1993) Botulinum neurotoxin A selectively cleaves the synaptic protein SNAP-25. Nature 365:160-163.

    Bragg DC, Sharma N (2014) Update on treatments for dystonia. Curr Neurol Neurosci Rep 14:454.

    Bril V1, Werb MR, Greene DA, Sima AA (1996) Single- fi ber electromyography in diabetic peripheral polyneuropathy. Muscle Nerve 19:2-9.

    Brin MF (1997) Botulinum toxin: chemistry, pharmacology, toxicity, and immunology. Muscle Nerve 6:S146-168, 20:146-168.

    Carli L, Montecucco C, Rossetto O (2009) Assay of diffusion of different botulinum neurotoxin type A formulations injected in the mouse leg. Muscle Nerve 40:374-380.

    Caroni P, Schneider C (1994a) Signaling by insulin-like growth factors in paralyzed skeletal muscle: rapid induction of IGFI expression in muscle fi bers and prevention of interstitial cell proliferation by IGFBP5 and IGF-BP4. J Neurosci 4:3378-3388.

    Caroni P, Schneider C, Kiefer MC, Zapf J (1994b) Role of muscle insulin like growth factors in nerve sprouting: suppression of terminal sprouting in paralyzed muscle by IGF-binding protein 4. J Cell boil 125:893-902.

    Chen S (2012) Clinical uses of botulinum neurotoxins: current indications,limitations and future developments. Toxins (Basel) 4:913-939.

    Costa LG, Deng H, Calleman CJ, Bergmark E (1995) Evaluation of the neurotoxicity of glycidamide, an epoxide metabolite of acrylamide: behavioral neurochemical and morphological studies. Toxicology 98:151-161.

    Dale WS, Derek S, Marvin AF (2002) Fast axonal transport: a site of Acrylamide: a rebuttal. Neurotoxicology 23:265-270.

    De Paiva A, Meunier FA, Molgo J, Aoki KR, Dolly JO (1999) Functional repair of motor endplates after botulinum neurotoxin type A poisoning: biphasic switch of synaptic activity between nerve sprouts and their parent terminals. Proc Natl Acad Sci U S A 96:3200-3205.

    Dong XM, Jiao XY, He FS (1989) Research of nerve pathology in rats poisoned with acrylamide. Weisheng Yanjiu 18:44-48.

    English AW (2003) Cytokines, growth factors and sprouting at the neuromuscular junction. J Neurocytol 32:943-960.

    Guo Y, Jin LJ, Liu WC, Zheng YG, Guan Q, Pan LZ, Nie ZY (2013) The impact of polyclonal neural cell adhesion molecule antibody on the potency of botulinum toxi. Yixue yu Kangfu Zazhi 35:833-838.

    Hao QY, Han MF, Rao ML (2000) Effect of acrylamide on the ions in nerve tissue of mouse. Zhongguo Gongye Yixue Zazhi 13:265-267.

    Harrison AR, Anderson BC, Thompson LV, McLoon LK (2007) Myofi ber length and three-dimensional localization of NMJs in normal and botulinum toxin treated adult extraocular muscles. Invest Ophthalmol Vis Sci 48:3594-3601.

    Harrison AR, Berbos Z, Zaldivar RA, Anderson BC, Semmer M, Lee MS, McLoon LK (2011) Modulating neuromuscular junction density changes in botulinum toxin-treated orbicularis oculi muscle. Invest Ophthalmol Vis Sci 52:982-986.

    Ho MC, Hsu WC, Hsieh YT (2014) Botulinum toxin type a injection for lateral canthal rhytids: effect on tear fi lm stability and tear production. JAMA Ophthalmol 132:332-337.

    Holds JB, Alderson K, Fogg SG, Anderson RL (1990) Motor nerve sprouting in human orbicularis muscle after botulinum A injection. Invest Ophthalmol Vis Sci 31:964-967.

    Juzans P, Comella JX, Molgo J, Faille L, Angaut-Petit D (1996) Nerve terminal sprouting in botulinum type-A treated mouse levator auris longus muscle. Neuromuscul Disord 6:177-185.

    Li G, Zhang SL, He FS (1989) Research of nerve electrophysiology in rats poisoned with acrylamide. Weisheng Yanjiu 18:4-6.

    Longa EZ, Weinstein PR, Carlson S, Cummins R (1989) Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke 20:84-91.

    Lopachin RM, Gavin T (2008) Acrylamide-induced nerve terminal damage: relevance to neurotoxic and neurodegenerative mechanisms. J Aqric Food Chem 56:5994-6003.

    Lu ZN, Wang ZZ (2000) Practical Electromyography. Beijing: People’s Health Publishing House 1:579-585.

    Matthew SM, Mary JM, Thomas FB (1983) Altered retrograde axonal transport of nerve growth factor after single and repeated dose of Acrylamide in the rat. Toxicol Appl Pharmacol 69:96-101.

    Meekins GD, Carter GT, Emery MJ, Weiss MD (2007) Axonal degeneration in the Trembler-j mouse demonstrated by stimulated single- fiber electromyography. Muscle Nerve 36:81-86.

    Meunier FA, Schiavo G, Molgo J (2002) Botulinum neurotoxins: from paralysis to recovery of functional neuromuscular transmission. J Physiol Paris 96:105-113.

    Pestronk A, Drachman DB (1988) Motor nerve outgrowth: reduced capacity for sprouting in the terminals of longer axons. Brain Res 463:218-222.

    Pimentel LH, Alencar FJ, Rodrigues LR, de Sousa FC, Mendes JB (2014) Effects of botulinum toxin type A for spastic foot in post-stroke patients enrolled in a rehabilitation program. Arq Neuropsiquiatr 72:28-32.

    Prasad SN, Muralidhara (2013) Neuroprotective efficacy of eugenol and isoeugenol in acrylamide-induced neuropathy in rats: behavioral and biochemical evidence. Neurochem Res 38:330-345.

    Rashid TG, Ockrim JL (2013) Male incontinence: onabotulinum toxin A and sacral nerve stimulation. Curr Opin Urol 23:545-551.

    Restivo DA, Pavone V, Nicotra A (2012) Single- fi ber electromyography in hyper C Kemia: the value of fi ber density. Neurol Sci 33:819-824.

    Rossetto O, Morbiato L, Caccin P, Rigoni M, Montecucco C (2006) Presynaptic enzymatic neurotoxins. J Neurochem 97:1534-1545.

    Santafe MM, Urbano FJ, Lanuza MA, Uchitel OD (2000) Multiple types of calcium channels mediate transmitter release during functional recovery of botulinum toxin type A-poisoned mouse motor nerve terminals. Neuroscience 95:227-234.

    Scelsi R, Candura SM (2012) Occupational toxic neuropathies: morphology in peripheral nerve biopsies. G Ital Med Lav Ergon 3:410-419.

    Shen J, Ma J, Lee C, Smith BP, Smith TL, Tan KH, Koman LA (2006) How muscles recover from paresis and atrophy after intramuscular injection of botulinum toxin A: study in juvenile rats. J Orthop Res 24:1128-1135.

    Sickles DW, Stone JD, Friedman MA (2002) Fast axonal transport a site of acrylamide neurotoxicity. Neurotoxicology 23:223-251.

    Simpson LL (1981) The origin, structure, and pharmacological activity of botulinum toxin. Pharmacol Rev 33:155-188.

    Thenganatt MA, Jankovic J (2014) Treatment of dystonia. Neurotherapeutics 11:139-152.

    Villafa?e JH, Fernandez-de-Las-Pe?as C, Pillastrini P (2012) Botulinum toxin type A combined with cervical spine manual therapy for masseteric hypertrophy in a patient with Alzheimer-type dementia: a case report. J Chiropr Med 11:280-285.

    Winocour S, Murad MH, Bidgoli-Moghaddam M, Jacobsona S, Bitea U, Saint-Cyra M, Trana N, Lemainea V (2014) A systematic review of the use of Botulinum toxin type A with subpectoral breast implants. J Plast Reconstr Aesthet Surg 67:34-41.

    Wright MC, Cho WJ, Son YJ (2007) Distinct patterns of motor nerve terminal sprouting induced by ciliary neurotrophic factor vs botulinum toxin. J Comp Neurol 504:1-16.

    Xiao JW, Niu Y, Zhang ZR, Yu CY, Li ZS (2013) Changes of ATPase in dorsal root ganglion induced by acrylamide. J Toxicol 27:235-238.

    Zhang YQ,Yao L, Wang GZ, Zhang YS (2008) Changes of neurobehavior function and electrophysiology in rats exposed to acrylamide. Chin Occup Med 35:278-280.

    Zhu YJ, Zeng T, Zhu YB, Yu SF, Wang QS, Zhang LP, Guo X, Xie KQ (2008) Effects of acrylamide the nervous tissue antioxidant system and sciatic nerve electrophysiology in the rat. Neurochem Res 33:2310-2317.

    Copyedited by Paul P, Norman C, Yang Y, Wang J, Li CH, Song LP, Zhao M

    Huaying Cai, M.D., Ph.D., Department of Neurology, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou 310016, Zhejiang Province, China, caihuaying2004@163.com.

    10.4103/1673-5374.139479

    http://www.nrronline.org/

    Accepted: 2014-07-03

    亚洲真实伦在线观看| 在线播放无遮挡| 日本撒尿小便嘘嘘汇集6| 亚洲av免费高清在线观看| 一个人免费在线观看电影| 日韩三级伦理在线观看| 在线观看一区二区三区| 亚洲成人中文字幕在线播放| 此物有八面人人有两片| 寂寞人妻少妇视频99o| av福利片在线观看| 欧美+日韩+精品| 天堂av国产一区二区熟女人妻| av黄色大香蕉| 晚上一个人看的免费电影| 国产亚洲欧美98| 亚洲成a人片在线一区二区| 国产麻豆成人av免费视频| 亚洲欧美中文字幕日韩二区| 亚洲最大成人手机在线| 俺也久久电影网| 国产亚洲av嫩草精品影院| 男插女下体视频免费在线播放| 一区二区三区免费毛片| 日韩高清综合在线| а√天堂www在线а√下载| 嫩草影院精品99| 狂野欧美激情性xxxx在线观看| 变态另类丝袜制服| 国产精品国产三级国产av玫瑰| 久久婷婷人人爽人人干人人爱| 精品国产三级普通话版| 亚洲精品日韩av片在线观看| 午夜福利18| 少妇人妻一区二区三区视频| 自拍偷自拍亚洲精品老妇| 亚洲精品一区av在线观看| 日本黄大片高清| 国产亚洲精品久久久久久毛片| 又黄又爽又免费观看的视频| 国产精品不卡视频一区二区| 国产av麻豆久久久久久久| 如何舔出高潮| 美女高潮的动态| 久久精品国产亚洲网站| 99在线视频只有这里精品首页| 一个人观看的视频www高清免费观看| 成人午夜高清在线视频| av在线播放精品| 国产精品女同一区二区软件| 久久精品综合一区二区三区| 亚洲熟妇中文字幕五十中出| 97超视频在线观看视频| 久久久成人免费电影| 男女做爰动态图高潮gif福利片| 深夜a级毛片| 亚洲欧美日韩无卡精品| 亚洲成人中文字幕在线播放| 亚洲国产精品sss在线观看| 人人妻人人澡欧美一区二区| 大型黄色视频在线免费观看| 午夜福利在线在线| 亚洲激情五月婷婷啪啪| 99久久久亚洲精品蜜臀av| 白带黄色成豆腐渣| 国内精品一区二区在线观看| 91在线观看av| 久久鲁丝午夜福利片| 看十八女毛片水多多多| 国产亚洲精品久久久久久毛片| 免费无遮挡裸体视频| 国产伦在线观看视频一区| 黄色配什么色好看| 人妻制服诱惑在线中文字幕| 三级男女做爰猛烈吃奶摸视频| 亚洲电影在线观看av| 国内精品美女久久久久久| ponron亚洲| 久久精品人妻少妇| 国产精品福利在线免费观看| 亚洲成人精品中文字幕电影| 国产精品综合久久久久久久免费| 国产三级中文精品| 人人妻,人人澡人人爽秒播| 又粗又爽又猛毛片免费看| 国产男靠女视频免费网站| 看非洲黑人一级黄片| 国产蜜桃级精品一区二区三区| 亚洲av成人av| 超碰av人人做人人爽久久| 尤物成人国产欧美一区二区三区| 成人亚洲精品av一区二区| 国产精品久久电影中文字幕| 淫妇啪啪啪对白视频| 联通29元200g的流量卡| 午夜视频国产福利| 人人妻人人看人人澡| 又黄又爽又免费观看的视频| 在线观看66精品国产| 久久热精品热| 色在线成人网| 色综合亚洲欧美另类图片| 精品久久国产蜜桃| 综合色丁香网| 精品久久久久久久末码| 午夜爱爱视频在线播放| 亚洲成a人片在线一区二区| 亚洲美女搞黄在线观看 | 亚洲真实伦在线观看| eeuss影院久久| 丰满人妻一区二区三区视频av| 精品午夜福利在线看| 亚洲最大成人av| 欧美激情在线99| 久久午夜亚洲精品久久| 国产美女午夜福利| 一卡2卡三卡四卡精品乱码亚洲| 久久久久精品国产欧美久久久| 国产色婷婷99| 国产av麻豆久久久久久久| 看免费成人av毛片| 色哟哟哟哟哟哟| 亚洲真实伦在线观看| 日韩制服骚丝袜av| 欧美精品国产亚洲| 俄罗斯特黄特色一大片| 久久天躁狠狠躁夜夜2o2o| 少妇人妻精品综合一区二区 | 日本爱情动作片www.在线观看 | 国产精品99久久久久久久久| 在线观看66精品国产| 一进一出抽搐gif免费好疼| 人人妻人人澡欧美一区二区| 最新中文字幕久久久久| 国产精品人妻久久久影院| 99九九线精品视频在线观看视频| 免费搜索国产男女视频| 插阴视频在线观看视频| 国产日本99.免费观看| 乱码一卡2卡4卡精品| 国产成人一区二区在线| 成人特级黄色片久久久久久久| 男人舔奶头视频| 日韩av不卡免费在线播放| 午夜a级毛片| 国产av在哪里看| 成人三级黄色视频| 人妻夜夜爽99麻豆av| 又粗又爽又猛毛片免费看| 国产成人91sexporn| 日韩欧美免费精品| 久久国内精品自在自线图片| 成人二区视频| 亚洲欧美日韩高清在线视频| 一个人看视频在线观看www免费| 不卡一级毛片| 亚洲欧美成人综合另类久久久 | 99精品在免费线老司机午夜| 色5月婷婷丁香| 国产极品精品免费视频能看的| 蜜臀久久99精品久久宅男| 99热只有精品国产| 美女xxoo啪啪120秒动态图| 久久国内精品自在自线图片| 成年女人毛片免费观看观看9| 国产精品一区二区免费欧美| 久久精品国产亚洲av涩爱 | 国产视频一区二区在线看| 日韩一本色道免费dvd| 国产精品久久久久久精品电影| 久久精品综合一区二区三区| 插阴视频在线观看视频| 欧美极品一区二区三区四区| 免费观看精品视频网站| 色5月婷婷丁香| 国产亚洲精品久久久久久毛片| 日日啪夜夜撸| 日日撸夜夜添| 深爱激情五月婷婷| 欧美色视频一区免费| 老司机午夜福利在线观看视频| 国产成人a区在线观看| 两性午夜刺激爽爽歪歪视频在线观看| 身体一侧抽搐| 久久这里只有精品中国| 亚洲最大成人av| 99久国产av精品国产电影| 午夜福利在线观看吧| 中文字幕av成人在线电影| 卡戴珊不雅视频在线播放| 人妻制服诱惑在线中文字幕| 日本一二三区视频观看| 亚洲综合色惰| 亚洲性久久影院| 又黄又爽又免费观看的视频| 嫩草影视91久久| 在线免费观看的www视频| 91在线精品国自产拍蜜月| 国产欧美日韩一区二区精品| 成年女人毛片免费观看观看9| 久久久久久久久中文| 夜夜看夜夜爽夜夜摸| 色噜噜av男人的天堂激情| 97在线视频观看| 久久国内精品自在自线图片| 校园春色视频在线观看| 少妇的逼水好多| 全区人妻精品视频| 精华霜和精华液先用哪个| 欧美性猛交黑人性爽| 日本欧美国产在线视频| 一卡2卡三卡四卡精品乱码亚洲| 在线播放无遮挡| 色哟哟哟哟哟哟| 亚洲一级一片aⅴ在线观看| 男女视频在线观看网站免费| 麻豆av噜噜一区二区三区| 青春草视频在线免费观看| 成人特级黄色片久久久久久久| 男女下面进入的视频免费午夜| 在线观看美女被高潮喷水网站| 国产精品美女特级片免费视频播放器| 亚洲在线观看片| 在线观看66精品国产| 国产一区二区在线观看日韩| 亚洲精品国产成人久久av| 日本欧美国产在线视频| 国产 一区 欧美 日韩| 小说图片视频综合网站| 精品久久久久久久久亚洲| 乱人视频在线观看| 久99久视频精品免费| 精品一区二区三区av网在线观看| 熟女电影av网| 久久精品国产亚洲av香蕉五月| 欧美激情在线99| 一级av片app| 免费av观看视频| 亚洲精品在线观看二区| 亚洲av美国av| 俺也久久电影网| 久久久精品大字幕| 我的老师免费观看完整版| 淫秽高清视频在线观看| 欧美中文日本在线观看视频| 国产精品人妻久久久久久| 亚洲国产高清在线一区二区三| 国产成人91sexporn| videossex国产| 亚洲图色成人| 伦理电影大哥的女人| 精品人妻视频免费看| 综合色av麻豆| 麻豆精品久久久久久蜜桃| 中文资源天堂在线| 日产精品乱码卡一卡2卡三| 乱人视频在线观看| 欧美3d第一页| 国产伦一二天堂av在线观看| 免费看a级黄色片| 淫秽高清视频在线观看| 韩国av在线不卡| 日韩欧美在线乱码| 日产精品乱码卡一卡2卡三| 国产精品爽爽va在线观看网站| 男人和女人高潮做爰伦理| 久久久久久久久久久丰满| 国语自产精品视频在线第100页| 搡老岳熟女国产| 精品免费久久久久久久清纯| 精品午夜福利视频在线观看一区| 国产成人freesex在线 | 久久久国产成人免费| 成人美女网站在线观看视频| 色哟哟哟哟哟哟| 99在线人妻在线中文字幕| 乱系列少妇在线播放| 小蜜桃在线观看免费完整版高清| 嫩草影视91久久| 日韩欧美免费精品| 干丝袜人妻中文字幕| 亚洲欧美日韩东京热| 久久精品久久久久久噜噜老黄 | h日本视频在线播放| 少妇被粗大猛烈的视频| 丝袜美腿在线中文| 一卡2卡三卡四卡精品乱码亚洲| 国产成人freesex在线 | 日本黄色片子视频| 免费av观看视频| av中文乱码字幕在线| 天美传媒精品一区二区| 色尼玛亚洲综合影院| 在线a可以看的网站| 色吧在线观看| 国产麻豆成人av免费视频| 成人精品一区二区免费| 一进一出抽搐gif免费好疼| 色哟哟·www| 精品一区二区三区视频在线| 亚洲欧美日韩高清在线视频| 三级国产精品欧美在线观看| 少妇的逼好多水| 中文字幕精品亚洲无线码一区| 亚洲欧美成人精品一区二区| 亚洲成人中文字幕在线播放| 岛国在线免费视频观看| 欧美极品一区二区三区四区| 亚洲专区国产一区二区| 精品国产三级普通话版| 午夜老司机福利剧场| 国产综合懂色| 熟女电影av网| 国产男人的电影天堂91| 国产美女午夜福利| 国产精品人妻久久久久久| 国产真实伦视频高清在线观看| 成人午夜高清在线视频| 精品久久久久久成人av| 中文亚洲av片在线观看爽| 亚洲三级黄色毛片| 99久久久亚洲精品蜜臀av| a级毛片免费高清观看在线播放| 99热全是精品| 91狼人影院| 日韩中字成人| 欧美在线一区亚洲| 精品久久久久久成人av| av天堂中文字幕网| 国产精品一及| 国产亚洲av嫩草精品影院| 看片在线看免费视频| 日本五十路高清| 欧美zozozo另类| 十八禁国产超污无遮挡网站| 日本黄大片高清| a级毛片a级免费在线| 男人狂女人下面高潮的视频| 国产黄片美女视频| 香蕉av资源在线| 别揉我奶头~嗯~啊~动态视频| 成人精品一区二区免费| av天堂在线播放| 日日摸夜夜添夜夜爱| 午夜久久久久精精品| 亚洲欧美精品自产自拍| 女生性感内裤真人,穿戴方法视频| 国产视频内射| 人妻制服诱惑在线中文字幕| 亚洲综合色惰| 国产精品嫩草影院av在线观看| 欧美高清成人免费视频www| 国产一区二区在线观看日韩| 日韩高清综合在线| 人妻丰满熟妇av一区二区三区| 亚洲一区二区三区色噜噜| 成人特级av手机在线观看| 极品教师在线视频| 大香蕉久久网| 十八禁网站免费在线| 精品人妻熟女av久视频| 一个人看视频在线观看www免费| 日日撸夜夜添| 欧美xxxx性猛交bbbb| 人妻制服诱惑在线中文字幕| 美女黄网站色视频| 亚洲人与动物交配视频| 不卡视频在线观看欧美| 91麻豆精品激情在线观看国产| 最近在线观看免费完整版| 国产精品人妻久久久久久| 少妇被粗大猛烈的视频| 男插女下体视频免费在线播放| 国产精品野战在线观看| 亚洲精品一区av在线观看| 亚洲国产精品成人综合色| 国产高清三级在线| 久久欧美精品欧美久久欧美| 成人午夜高清在线视频| 男女那种视频在线观看| 亚洲精品日韩在线中文字幕 | 久久久久久大精品| 一卡2卡三卡四卡精品乱码亚洲| 亚洲第一区二区三区不卡| 国产亚洲91精品色在线| 啦啦啦啦在线视频资源| 在线观看免费视频日本深夜| 亚洲熟妇熟女久久| 干丝袜人妻中文字幕| 国产视频一区二区在线看| 日韩强制内射视频| 亚洲图色成人| 久久欧美精品欧美久久欧美| 嫩草影院入口| 久久久久久久久中文| 久久久成人免费电影| 亚洲精品久久国产高清桃花| 亚洲图色成人| 大型黄色视频在线免费观看| 国产精品一区二区三区四区久久| 国产精品美女特级片免费视频播放器| 国产毛片a区久久久久| 国产一区二区在线av高清观看| 中文字幕免费在线视频6| 99久久久亚洲精品蜜臀av| 搡老妇女老女人老熟妇| 久久久久久久亚洲中文字幕| 久久人人精品亚洲av| 18禁在线无遮挡免费观看视频 | 五月玫瑰六月丁香| 日本黄色片子视频| 成年女人看的毛片在线观看| 亚洲欧美日韩卡通动漫| 一级毛片aaaaaa免费看小| 少妇被粗大猛烈的视频| 51国产日韩欧美| 黄色一级大片看看| 亚洲熟妇熟女久久| 国产精品久久久久久久久免| 午夜福利在线观看免费完整高清在 | 国产精品乱码一区二三区的特点| 日韩三级伦理在线观看| 欧美中文日本在线观看视频| 精品一区二区三区视频在线观看免费| 搡老妇女老女人老熟妇| 久久久精品大字幕| 色噜噜av男人的天堂激情| 熟女人妻精品中文字幕| 亚洲成人av在线免费| 国产精品爽爽va在线观看网站| 国产aⅴ精品一区二区三区波| 国产午夜精品久久久久久一区二区三区 | 搡老妇女老女人老熟妇| 少妇的逼水好多| 无遮挡黄片免费观看| 俺也久久电影网| 搡老熟女国产l中国老女人| 黑人高潮一二区| 蜜桃久久精品国产亚洲av| 日韩av不卡免费在线播放| 天天躁日日操中文字幕| 久久久久久久久中文| 精品午夜福利在线看| 精品久久久久久成人av| 自拍偷自拍亚洲精品老妇| 午夜精品在线福利| 白带黄色成豆腐渣| 欧美性猛交╳xxx乱大交人| 亚洲人与动物交配视频| 又爽又黄a免费视频| 国产午夜精品久久久久久一区二区三区 | 日日干狠狠操夜夜爽| 欧美潮喷喷水| 岛国在线免费视频观看| 老师上课跳d突然被开到最大视频| 国产精品福利在线免费观看| 最近在线观看免费完整版| 一级黄色大片毛片| 美女xxoo啪啪120秒动态图| 欧美最黄视频在线播放免费| 99久久精品热视频| 亚洲欧美精品综合久久99| 国产男靠女视频免费网站| 在现免费观看毛片| 亚洲av二区三区四区| 日韩欧美免费精品| 成人一区二区视频在线观看| 亚洲一级一片aⅴ在线观看| 国产单亲对白刺激| 日韩精品青青久久久久久| 1024手机看黄色片| 日本成人三级电影网站| 日本爱情动作片www.在线观看 | 波多野结衣高清作品| 蜜桃久久精品国产亚洲av| 男女啪啪激烈高潮av片| 给我免费播放毛片高清在线观看| 少妇熟女aⅴ在线视频| 激情 狠狠 欧美| 亚洲人成网站高清观看| 日韩制服骚丝袜av| 欧美成人免费av一区二区三区| 自拍偷自拍亚洲精品老妇| 国产美女午夜福利| 身体一侧抽搐| 午夜福利视频1000在线观看| 在线a可以看的网站| 欧美zozozo另类| 国产成人freesex在线 | 亚洲丝袜综合中文字幕| 深夜精品福利| 中文字幕人妻熟人妻熟丝袜美| 国产不卡一卡二| 又爽又黄无遮挡网站| 国产三级在线视频| 在线免费观看不下载黄p国产| 日韩欧美 国产精品| 亚洲欧美清纯卡通| 网址你懂的国产日韩在线| 丝袜美腿在线中文| 久久久久国产网址| 18禁在线播放成人免费| 在线国产一区二区在线| 国产一区二区在线av高清观看| 99久久成人亚洲精品观看| 久久亚洲精品不卡| 99热这里只有精品一区| 五月伊人婷婷丁香| 精品日产1卡2卡| av国产免费在线观看| 啦啦啦啦在线视频资源| 免费看a级黄色片| 狂野欧美白嫩少妇大欣赏| 国产精品综合久久久久久久免费| 精品欧美国产一区二区三| 不卡一级毛片| 国产精华一区二区三区| 全区人妻精品视频| 欧美成人一区二区免费高清观看| 99久久九九国产精品国产免费| av视频在线观看入口| 久久久久国产精品人妻aⅴ院| а√天堂www在线а√下载| 两性午夜刺激爽爽歪歪视频在线观看| 中文字幕熟女人妻在线| a级一级毛片免费在线观看| 变态另类丝袜制服| 99精品在免费线老司机午夜| 少妇的逼好多水| 免费观看精品视频网站| 亚洲精品粉嫩美女一区| 国产精品电影一区二区三区| 国产成人福利小说| 99久久精品一区二区三区| 国产一区二区在线av高清观看| 国产欧美日韩精品一区二区| 精品久久国产蜜桃| 免费一级毛片在线播放高清视频| 国产一区二区在线av高清观看| 小蜜桃在线观看免费完整版高清| 97在线视频观看| 真人做人爱边吃奶动态| 丰满乱子伦码专区| 亚洲成av人片在线播放无| 欧美性猛交黑人性爽| 人人妻人人看人人澡| 成人特级av手机在线观看| 欧美日本视频| 我要看日韩黄色一级片| 中文资源天堂在线| 在线观看美女被高潮喷水网站| 午夜视频国产福利| 日韩制服骚丝袜av| 免费看av在线观看网站| 久久国产乱子免费精品| 久久久国产成人免费| 国产精品国产高清国产av| 六月丁香七月| 九九在线视频观看精品| 久久久久九九精品影院| 夜夜看夜夜爽夜夜摸| 国产成人影院久久av| 高清午夜精品一区二区三区 | 六月丁香七月| 中文亚洲av片在线观看爽| 99riav亚洲国产免费| 夜夜看夜夜爽夜夜摸| 久久九九热精品免费| 一进一出抽搐gif免费好疼| 别揉我奶头~嗯~啊~动态视频| 国产三级中文精品| 免费看av在线观看网站| eeuss影院久久| 别揉我奶头 嗯啊视频| 久久中文看片网| 联通29元200g的流量卡| 国产精品日韩av在线免费观看| 赤兔流量卡办理| 免费大片18禁| 欧美不卡视频在线免费观看| 欧美在线一区亚洲| 欧美区成人在线视频| 在现免费观看毛片| 大型黄色视频在线免费观看| 夜夜夜夜夜久久久久| 3wmmmm亚洲av在线观看| 国产精品永久免费网站| 免费电影在线观看免费观看| 亚洲人成网站高清观看| АⅤ资源中文在线天堂| 18+在线观看网站| 中国国产av一级| 两性午夜刺激爽爽歪歪视频在线观看| 成人午夜高清在线视频| 婷婷精品国产亚洲av| 国产成人影院久久av| 亚洲成人久久性| a级毛色黄片| 97人妻精品一区二区三区麻豆| 亚洲av电影不卡..在线观看| 久久久久久伊人网av| 亚洲三级黄色毛片| 最近视频中文字幕2019在线8| 少妇熟女aⅴ在线视频| 久久午夜福利片| 国产免费一级a男人的天堂| 麻豆乱淫一区二区| 国产男靠女视频免费网站| 蜜桃亚洲精品一区二区三区| 日韩精品有码人妻一区| 欧洲精品卡2卡3卡4卡5卡区| 欧美精品国产亚洲| 看黄色毛片网站| 天美传媒精品一区二区| 亚洲专区国产一区二区|